Adjunctive fecal microbiota transplantation in supportive oncology: Emerging indications and considerations in immunocompromised patients

FMT has gained enormous momentum in the treatment of acute inflammatory and infectious diseases. Despite an encouraging safety profile, FMT has been met with caution in the oncological setting due to perceived infectious risks in immunocompromised patients. Theoretical risks aside, the application o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wardill, H.R., Secombe, K.R., Bryant, R.V., Hazenberg, M.D., Costello, S.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603490/
https://www.ncbi.nlm.nih.gov/pubmed/30940601
http://dx.doi.org/10.1016/j.ebiom.2019.03.070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603490/
https://www.ncbi.nlm.nih.gov/pubmed/30940601
http://dx.doi.org/10.1016/j.ebiom.2019.03.070

Ejemplares similares